1. |
董家鸿. 弘扬志强精神 开创精准胆道外科的新时代. 中华消化外科杂志, 2016, 15(4): 307-309.
|
2. |
Nagino M, Ebata T, Yokoyama Y, et al. Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections. Ann Surg, 2013, 258(1): 129-140.
|
3. |
Chevrou-Séverac H, Pinget C, Cerantola Y, et al. Cost-effectiveness analysis of immune-modulating nutritional support for gastrointestinal cancer patients. Clin Nutr, 2014, 33(4): 649-654.
|
4. |
Yubin L, Chihua F, Zhixiang J, et al. Surgical management and prognostic factors of hilar cholangiocarcinoma: experience with 115 cases in China. Ann Surg Oncol, 2008, 15(8): 2113-2119.
|
5. |
陈孝平. 肝门部胆管癌外科治疗的前景与挑战. 腹部外科, 2010, 23(2): 68-69.
|
6. |
Imamura H, Seyama Y, Kokudo N, et al. One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg, 2003, 138(11): 1198-1206.
|
7. |
Poon RT, Fan ST, Lo CM, et al. Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1 222 consecutive patients from a prospective database. Ann Surg, 2004, 240(4): 698-708.
|
8. |
Asiyanbola B, Chang D, Gleisner AL, et al. Operative mortality after hepatic resection: are literature-based rates broadly applicable? J Gastrointest Surg, 2008, 12(5): 842-851.
|
9. |
Kooby DA, Stockman J, Ben-Porat L, et al. Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg, 2003, 237(6): 860-869.
|
10. |
Wei AC, Tung-Ping Poon R, Fan ST, et al. Risk factors for perioperative morbidity and mortality after extended hepatectomy for hepatocellular carcinoma. Br J Surg, 2003, 90(1): 33-41.
|
11. |
刘连新, 尹大龙. 肝癌肝切除术后常见并发症与处理. 中华普外科手术学杂志 (电子版), 2014, 8(1): 23-25.
|
12. |
Yang T, Li L, Zhong Q, et al. Risk factors of hospital mortality after re-laparotomy for post-hepatectomy hemorrhage. World J Surg, 2013, 37(10): 2394-2401.
|
13. |
Lim C, Dokmak S, Farges O, et al. Reoperation for post-hepatectomy hemorrhage: increased risk of mortality. Langenbecks Arch Surg, 2014, 399(6): 735-740.
|
14. |
Rahbari NN, Garden OJ, Padbury R, et al. Post-hepatectomy haemorrhage: a definition and grading by the International Study Group of Liver Surgery (ISGLS). HPB (Oxford), 2011, 13(8): 528-535.
|
15. |
Nomi T, Fuks D, Govindasamy M, et al. Risk factors for complications after laparoscopic major hepatectomy. Br J Surg, 2015, 102(3): 254-260.
|
16. |
罗祥基, 张柏和. 肝门部胆管癌术后严重并发症的防治. 实用肿瘤杂志, 2007, 22(2): 175-177.
|
17. |
邢宝才, 徐达. 肝切除术后出血的诊疗策略. 肝癌电子杂志, 2015, 2(1): 25-28.
|
18. |
胡骁, 胡维昱, 孙传东, 等. 肝门部胆管癌根治性切除术后并发症的诊断和治疗. 中国现代普通外科进展, 2015, 18(4): 328-330.
|
19. |
李相成, 季顾惟. 肝门部胆管癌的根治性切除. 外科理论与实践, 2017, 22(3): 185-190.
|
20. |
尹大龙, 刘连新. 肝门部胆管癌根治性切除术前评估策略. 肝胆外科杂志, 2017, 25(2): 84-86.
|
21. |
Ni Q, Wang H, Zhang Y, et al. MDCT assessment of resectability in hilar cholangiocarcinoma. Abdom Radiol (NY), 2017, 42(3): 851-860.
|
22. |
Madhusudhan KS, Gamanagatti S, Gupta AK. Imaging and interventions in hilar cholangiocarcinoma: a review. World J Radiol, 2015, 7(2): 28-44.
|
23. |
Zeng N, Tao H, Fang C, et al. Individualized preoperative planning using three-dimensional modeling for Bismuth and Corlette type Ⅲ hilar cholangiocarcinoma. World J Surg Oncol, 2016, 14(1): 44.
|
24. |
陈康, 熊力, 郑砚文. 3D 打印技术在肝脏外科应用现状及展望. 中国普通外科杂志, 2017, 26(1): 90-95.
|
25. |
Lambrecht JT, Berndt DC, Schumacher R, et al. Generation of three-dimensional prototype models based on cone beam computed tomography. Int J Comput Assist Radiol Surg, 2009, 4(2): 175-180.
|
26. |
Shirabe K, Kajiyama K, Harimoto N, et al. Risk factors for massive bleeding during major hepatectomy. World J Surg, 2010, 34(7): 1555-1562.
|
27. |
Yang T, Zhang J, Lu JH, et al. A new staging system for resectable hepatocellular carcinoma: comparison with six existing staging systems in a large Chinese cohort. J Cancer Res Clin Oncol, 2011, 137(5): 739-750.
|
28. |
Gawande AA, Kwaan MR, Regenbogen SE, et al. An Apgar score for surgery. J Am Coll Surg, 2007, 204(2): 201-208.
|
29. |
刘养岁, 张昕辉, 李欢送, 等. 外科 Apgar 评分对肝门部胆管癌患者术后风险的评估作用. 临床外科杂志, 2017, 25(6): 426-429.
|
30. |
中国抗癌协会. 肝门部胆管癌规范化诊治专家共识 (2015). 中华肝胆外科杂志, 2015, 21(8): 505-511.
|
31. |
Gupta D, Vashi PG, Lammersfeld CA, et al. Role of nutritional status in predicting the length of stay in cancer: a systematic review of the epidemiological literature. Ann Nutr Metab, 2011, 59(2/4): 96-106.
|
32. |
郭剑, 周永斌, 翟泽民, 等. 肝门部胆管癌患者营养不良评估与术后发症的相研究. 中华全科医学, 2016, 14(8): 1266-1268.
|
33. |
李澄云, 牛秀峰, 倪家连. 术前减黄对肝门部胆管癌手术效果的影响. 肝胆胰外科杂志, 2017, 29(3): 203-206.
|
34. |
殷晓煜. 肝门部胆管癌手术治疗的热点与难点. 中华肝脏外科手术学电子杂志, 2017, 6(2): 81-84.
|
35. |
王辉, 王坚, 王昊陆, 等. 影响肝门部胆管癌术后生存率的多因素分析. 外科理论与实践, 2014, 19(5): 444-448.
|
36. |
董家鸿, 郑树森, 陈孝平, 等. 肝切除术前肝脏储备功能评估的专家共识 (2011 版). 中华消化外科杂志, 2011, 10(1): 20-25.
|
37. |
晏益核, 黄玉斌, 蔡小勇. 肝门部胆管癌的外科治疗现状. 中国普通外科杂志, 2017, 26(2): 246-251.
|
38. |
Furusawa N, Kobayashi A, Yokoyama T, et al. Surgical treatment of 144 cases of hilar cholangiocarcinoma without liver-related mortality. World J Surg, 2014, 38(5): 1164-1176.
|
39. |
齐卫鹏, 王剑明, 张剑, 等. 联合血管切除重建在肝门部胆管癌根治术中的应用 (附 16 例病例分析). 中国医师进修杂志, 2016, 39(7): 627-630.
|
40. |
Carless PA, Henry DA, Anthony DM. Fibrin sealant use for minimising peri-operative allogeneic blood transfusion. Cochrane Database Syst Rev, 2003, (2): CD004171.
|
41. |
Boonstra EA, Molenaar IQ, Porte RJ, et al. Topical haemostatic agents in liver surgery: do we need them? HPB (Oxford), 2009, 11(4): 306-310.
|
42. |
冯金鸽, 郑晓燕, 安琳, 等. 加速康复外科在肝门部胆管癌手术患者中的应用. 临床医学研究与实践, 2016, 1(15): 143-145.
|
43. |
中国研究型医院学会肝胆胰外科专业委员会. 肝胆胰外科术后加速康复专家共识 (2015 版). 中华消化外科杂志, 2016, 15(1): 1-6.
|
44. |
Balzan S, Belghiti J, Farges O, et al. The " 50-50 criteria” on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg, 2005, 242(6): 824-828.
|
45. |
中华医学会外科学分会外科手术学学组. 肝切除术后加速康复中国专家共识 (2017 版) 临床肝胆病杂志, 2017, 33(10): 1876-1882.
|
46. |
张永杰, 邱应和, 沈宁佳. 胆胰外科术后迟发型性出血的介入治疗. 中华肝脏外科手术学电子杂志, 2017, 6(3): 164-167.
|
47. |
Fujii Y, Shimada H, Endo I, et al. Management of massive arterial hemorrhage after pancreatobiliary surgery: does embolotherapy contribute to successful outcome? J Gastrointest Surg, 2007, 11(4): 432-438.
|
48. |
Rau C, Blanc B, Ronot M, et al. Neither preoperative computed tomography nor intra-operative examination can predict metastatic lymph node in the hepatic pedicle in patients with colorectal liver metastasis. Ann Surg Oncol, 2012, 19(1): 163-168.
|
49. |
Beyer L, Bonmardion R, Marciano S, et al. Results of non-operative therapy for delayed hemorrhage after pancreaticoduodenectomy. J Gastrointest Surg, 2009, 13(5): 922-928.
|
50. |
Aragon RJ, Solomon NL. 肝脏切除技术. 中国普通外科杂志, 2013, 22(7): 818-827.
|
51. |
Richardson AJ, Laurence JM, Lam VW. Portal triad clamping versus other methods of vascular control in liver resection: a systematic review and meta-analysis. HPB (Oxford), 2012, 14(6): 355-364.
|